Vaginal microbiome influences HIV acquisition.
Sign Up to like & getrecommendations! Published in 2017 at "Science"
DOI: 10.1126/science.356.6341.918-g
Abstract: HIV Clinical Trials![Figure][1] Gardnerella vaginalis can hinder tenofovir's efficacy in HIV prophylaxis. PHOTO: STEM JEMS/GETTY IMAGES Tenofovir is a preexposure drug used to prevent HIV infection. In clinical trials, tenofovir was effective for men, but… read more here.
Keywords: microbiome influences; influences hiv; hiv acquisition; vaginal microbiome ... See more keywords